← Back to markets
Repligen
RGEN · Health Care · Life Sciences Tools & Services
$163.90+2.75%
RS +18.6
Returns
| 7D | +16.2% |
| 1M | +13.9% |
| 3M | +29.6% |
| 6M | +17.4% |
| YTD | +0.0% |
| 1Y | +46.2% |
About Repligen
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.